Tokyo, Japan
As a creator, investor, and enterprise builder, I’ve spent my career launching and scaling high-impact ventures across the U.S., Europe, and Asia. With a foundation in business development, I transitioned into hands-on leadership—building and exiting three companies in the biomedical engineering and medical device space. Today, I lead COVUE, a fully integrated Japan Market Entry platform purpose-built for OEMs, B2B manufacturers, and global consumer brands. Our model replaces fragmented vendor networks with direct operations and licensing—delivering end-to-end execution in one of the world’s most complex markets. Core capabilities: Import & Market Compliance | Logistics | eCommerce | Retail | Marketing & Advertising | Product Finishing & Manufacturing | Customer Care | Depot Repair | Field Service Whether launching a D2C wellness brand, SAS, or operating white-labeled after-sales services for global medical device and electronics OEMs—COVUE is where global growth meets Japanese precision.
Supporting 500+ brands with a combined annual sales of 1.1T¥ ($7.8B). COVUE is a Japan-based operational platform engineered to simplify and accelerate market entry for foreign brands. As a full end-to-end service provider, COVUE enables global companies to import, register, store, sell, and support products in Japan without establishing a local entity. COVUE operates as both a licensed business operator and a strategic extension of our clients’ organizations. We manage the physical, regulatory, digital, and commercial infrastructure required to ensure that our clients can operate compliantly and competitively in the Japanese market. Our platform integrates compliance, logistics, fiscal representation, commerce, and client support into one synchronized ecosystem — designed to minimize friction, accelerate growth, and deliver exceptional local experiences.
Medical Device Company (Now Seacrown) http://www.seacrown.cn/
Now Seacrown http://www.seacrown.cn/ VIVID IMAGING launched as a Medical Device Service Support Company. Held executive oversight of this organic build out and served as the primary investor. Targeted contrast injector market as third-party service company. Achieve mid-double digit growth year on year. Secured exclusive support agreements with three of the five largest MVS groups in the US. Company became largest third-party service provider for contrast injectors in the US. Verticalized business into medical device design, manufacturing and global commercialization. Today, company specializes in contrast media injectors with focus on a customized value range product line for MRI, Computed Tomography, Mammography and Angiography for OEMs and RX Manufacturers. Business Acquired.
Clinical Engineering - Serving as a primary investor, executed acquisition of this business unit. Achieved double-digit growth year on year during tenure. Captured 80% of west coast public sector business by month 24. Drove private sector growth across nine states. Established east coast footprint supporting the tri-state healthcare market. The business was acquired under a roll-up.
From concept to launch... New subsidiary: Maintenance Insurance Asset Management business for healthcare provider market achieving +250% of growth target in year one. Implemented supporting clinical engineering business across west coast market.